Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lung Neoplasms × Genistein × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1

Interventions

Carboplatin 152 Paclitaxel 111 Radiotherapy 110 Cisplatin 101 Docetaxel 85 Gemcitabine 76 Pemetrexed 72 Erlotinib Hydrochloride 70 Bevacizumab 45 Etoposide 38 pembrolizumab 31 Vinorelbine 30 Topotecan 28 Gefitinib 26 Irinotecan 25 Surveys and Questionnaires 23 Radiosurgery 18 Magnetic Resonance Spectroscopy 18 Drug Therapy 18 Nivolumab 17 Cetuximab 16 durvalumab 15 Cyclophosphamide 15 Surgical Procedures, Operative 14 Immunohistochemistry 14 Celecoxib 14 Gene Expression Profiling 13 Filgrastim 13 Early Intervention, Educational 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02567799 2024-01-25

NSCLC

Humanetics Corporation

Phase 1/2 Completed

21 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡